LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 96

Search options

  1. Article ; Online: Histoplasmosis of the left wrist in an immunosuppressed host with myasthenia gravis

    Noor Abdulhameed / Omar Abdul-Aziz / Meghan Sawyer / Caitlyn Hollingshead, MD / Salman Arif, MD

    Translation, Vol 11, Iss

    2023  Volume 3

    Keywords Infectious Diseases ; Fungal Infection ; Case Report ; Medicine (General) ; R5-920
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher The University of Toledo
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator.

    Kaur, Gurmeet / Belotti, Dorina / Burger, Angelika M / Fisher-Nielson, Kirsten / Borsotti, Patrizia / Riccardi, Elena / Thillainathan, Jagada / Hollingshead, Melinda / Sausville, Edward A / Giavazzi, Raffaella

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2024  Volume 30, Issue 9, Page(s) 1996

    Language English
    Publishing date 2024-05-01
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-24-0857
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture.

    Wojcik, Heather M / Lovvorn, Harold N / Hollingshead, Melinda / Pierce, Janene / Stotler, Howard / Murphy, Andrew J / Borgel, Suzanne / Phelps, Hannah M / Correa, Hernan / Perantoni, Alan O

    Frontiers in oncology

    2023  Volume 13, Page(s) 1091274

    Abstract: Introduction: Wilms Tumor (WT), or nephroblastoma, is the most common pediatric kidney cancer. Most WTs display a "favorable" triphasic histology, in which the tumor is comprised of blastemal, stromal, and epithelial cell types. Blastemal predominance ... ...

    Abstract Introduction: Wilms Tumor (WT), or nephroblastoma, is the most common pediatric kidney cancer. Most WTs display a "favorable" triphasic histology, in which the tumor is comprised of blastemal, stromal, and epithelial cell types. Blastemal predominance after neoadjuvant chemotherapy or diffuse anaplasia ("unfavorable" histology; 5-8%) portend a worse prognosis. Blastema likely provide the putative cancer stem cells (CSCs), which retain molecular and histologic features characteristic of nephron progenitor cells (NPCs), within WTs. NPCs arise in the metanephric mesenchyme (MM) and populate the cap mesenchyme (CM) in the developing kidney. WT blastemal cells, like NPCs, similarly express markers, SIX2 and CITED1. Tumor xenotransplantation is currently the only dependable method to propagate tumor tissue for research or therapeutic screening, since efforts to culture tumors
    Methods: Previously, our lab developed niche conditions that support the propagation of murine NPCs in culture. Applying similar conditions to WTs, we assessed our ability to maintain key NPC "stemness" markers, SIX2, NCAM, and YAP1, and CSC marker ALDHI in cells from five distinct untreated patient tumors.
    Results: Accordingly, our culture conditions maintained the expression of these markers in cultured WT cells through multiple passages of rapidly dividing cells.
    Discussion: These findings suggest that our culture conditions sustain the WT blastemal population, as previously shown for normal NPCs. As a result, we have developed new WT cell lines and a multi-passage
    Language English
    Publishing date 2023-03-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2023.1091274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.

    Yang, Sherry X / Hollingshead, Melinda / Rubinstein, Larry / Nguyen, Dat / Larenjeira, Angelo B A / Kinders, Robert J / Difilippantonio, Michael / Doroshow, James H

    Journal of hematology & oncology

    2021  Volume 14, Issue 1, Page(s) 83

    Abstract: Background: Challenges remain on the selection of patients who potentially respond to a class of drugs that target epigenetics for cancer treatment. This study aims to investigate TET2/DNMT3A mutations and antitumor activity of a novel epigenetic agent ... ...

    Abstract Background: Challenges remain on the selection of patients who potentially respond to a class of drugs that target epigenetics for cancer treatment. This study aims to investigate TET2/DNMT3A mutations and antitumor activity of a novel epigenetic agent in multiple human cancer cell lines and animal models.
    Methods: Seventeen cancer cell lines and multiple xenograft models bearing representative human solid tumors were subjected to 4'-thio-2'-deoxycytidine (T-dCyd) or control treatment. Gene mutations in cell lines were examined by whole exome and/or Sanger sequencing. Specific gene expression was measured in cells and xenograft tumor samples by Western blotting and immunohistochemistry. TET2/DNMT3A mutation status in 47,571 human tumor samples was analyzed at cBioPortal for Cancer Genomics.
    Results: Cell survival was significantly inhibited by T-dCyd in breast BT549, lung NCI-H23, melanoma SKMEL5 and renal ACHN cancer lines harboring deleterious TET2 and nonsynonymous DNMT3A mutations compared to 13 lines without such mutation pattern (P = 0.007). The treatment upregulated p21 and induced cell cycle arrest in NCI-H23 cells, and dramatically inhibited their xenograft tumor growth versus wildtype models. T-dCyd administrations led to a significant p21 increase and near eradication of tumor cells in the double-mutant xenografts by histological evaluation. TET2/DNMT3A was co-mutated in human lung, breast, skin and kidney cancers and frequently in angioimmunoblastic and peripheral T cell lymphomas and several types of leukemia.
    Conclusions: Cell and animal models with concurrent mutations in TET2 and DNMT3A were sensitive to T-dCyd treatment. The mutations were detectable in human solid tumors and frequently occur in some hematological malignancies.
    MeSH term(s) Animals ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; DNA (Cytosine-5-)-Methyltransferases/genetics ; DNA (Cytosine-5-)-Methyltransferases/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/pharmacology ; Female ; HCT116 Cells ; Humans ; MCF-7 Cells ; Mice ; Mice, Nude ; Mutation ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; Thionucleosides/pharmacology ; Xenograft Model Antitumor Assays
    Chemical Substances Biomarkers, Tumor ; DNA-Binding Proteins ; Proto-Oncogene Proteins ; Thionucleosides ; Deoxycytidine (0W860991D6) ; 2'-deoxy-4'-thiocytidine (134111-30-1) ; TET2 protein, human (EC 1.13.11.-) ; DNA (Cytosine-5-)-Methyltransferases (EC 2.1.1.37) ; DNA methyltransferase 3A (EC 2.1.1.37)
    Language English
    Publishing date 2021-05-26
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2429631-4
    ISSN 1756-8722 ; 1756-8722
    ISSN (online) 1756-8722
    ISSN 1756-8722
    DOI 10.1186/s13045-021-01091-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Intraperitoneal and subcutaneous tumor models for assessing anti-neoplastic agents in rodents.

    Hollingshead, Melinda

    Current protocols in pharmacology

    2002  Volume Chapter 5, Page(s) Unit 5.28

    Abstract: Evaluation of compounds for in vivo antineoplastic activity can be achieved in a variety of animal models. Two models commonly employed for these studies are the intraperitoneal challenge survival model and the subcutaneous tumor implant model. The ... ...

    Abstract Evaluation of compounds for in vivo antineoplastic activity can be achieved in a variety of animal models. Two models commonly employed for these studies are the intraperitoneal challenge survival model and the subcutaneous tumor implant model. The challenge survival model involves intraperitoneal tumor inoculation, test compound treatment and monitoring for survival. This assay can be modulated for stringency by altering the treatment dose, route and schedule. The second model, subcutaneous tumor implants, is more strenuous as the test compound must cross physiologic barriers to reach the target tumor. Additionally, the subcutaneous model is more labor intensive to setup, monitor and evaluate.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Cell Proliferation ; Disease Models, Animal ; HL-60 Cells ; Humans ; Melanoma/drug therapy ; Melanoma/pathology ; Mice ; Mice, Nude ; Mice, SCID ; Neoplasm Staging/methods ; Neoplasm Transplantation/methods ; Peritoneal Neoplasms/drug therapy ; Peritoneal Neoplasms/pathology ; Random Allocation ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Xenograft Model Antitumor Assays/methods
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2002-11
    Publishing country United States
    Document type Journal Article
    ISSN 1934-8290
    ISSN (online) 1934-8290
    DOI 10.1002/0471141755.ph0528s18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.

    Zelasko, S / Hollingshead, M / Castillo, M / Bouldin, T W

    AJNR. American journal of neuroradiology

    2008  Volume 29, Issue 10, Page(s) 1880–1882

    Abstract: We present a patient with progressive dural calcifications, thickening, and enhancement presumably related to the development of nephrogenic systemic fibrosis (NSF). Head CT demonstrated progressive dural calcifications, whereas MR imaging demonstrated ... ...

    Abstract We present a patient with progressive dural calcifications, thickening, and enhancement presumably related to the development of nephrogenic systemic fibrosis (NSF). Head CT demonstrated progressive dural calcifications, whereas MR imaging demonstrated progressive dural thickening and enhancement during a 3-year period in which the patient received several gadolinium-enhanced MR imaging studies. To the best of our knowledge, dural calcifications are the only described intracranial finding of NSF.
    MeSH term(s) Brain Diseases/diagnosis ; Contrast Media ; Dura Mater/diagnostic imaging ; Dura Mater/pathology ; Female ; Gadolinium ; Humans ; Magnetic Resonance Imaging ; Middle Aged ; Nephrogenic Fibrosing Dermopathy/complications ; Nephrogenic Fibrosing Dermopathy/diagnosis ; Tomography, X-Ray Computed/methods
    Chemical Substances Contrast Media ; Gadolinium (AU0V1LM3JT)
    Language English
    Publishing date 2008-10-14
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 603808-6
    ISSN 1936-959X ; 0195-6108
    ISSN (online) 1936-959X
    ISSN 0195-6108
    DOI 10.3174/ajnr.A1225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug-induced DNA double strand breaks from DNA double strand breaks associated with apoptosis.

    Dull, Angie B / Wilsker, Deborah / Hollingshead, Melinda / Mazcko, Christina / Annunziata, Christina M / LeBlanc, Amy K / Doroshow, James H / Kinders, Robert J / Parchment, Ralph E

    Oncotarget

    2018  Volume 9, Issue 24, Page(s) 17104–17116

    Abstract: DNA double strand breaks (DSBs) induced by cancer therapeutic agents can lead to DNA damage repair or persistent DNA damage, which can induce apoptotic cell death; however, apoptosis also induces DSBs independent of genotoxic insult. γH2AX is an ... ...

    Abstract DNA double strand breaks (DSBs) induced by cancer therapeutic agents can lead to DNA damage repair or persistent DNA damage, which can induce apoptotic cell death; however, apoptosis also induces DSBs independent of genotoxic insult. γH2AX is an established biomarker for DSBs but cannot distinguish between these mechanisms. Activated cleaved caspase-3 (CC3) promotes apoptosis by enhancing nuclear condensation, DNA fragmentation, and plasma membrane blebbing. Here, we describe an immunofluorescence assay that distinguishes between apoptosis and drug-induced DSBs by measuring coexpression of γH2AX and membrane blebbing-associated CC3 to indicate apoptosis, and γH2AX in the absence of CC3 blebbing to indicate drug-induced DNA damage. These markers were examined in xenograft models following treatment with topotecan, cisplatin, or birinapant. A topotecan regimen conferring tumor regression induced tumor cell DSBs resulting from both apoptosis and direct DNA damage. In contrast, a cisplatin regimen yielding tumor growth delay, but not regression, resulted in tumor cell DSBs due solely to direct DNA damage. MDA-MB-231 xenografts exposed to birinapant, which promotes apoptosis but does not directly induce DSBs, exhibited dose-dependent increases in colocalized γH2AX/CC3 blebbing in tumor cells. Clinical feasibility was established using formalin-fixed, paraffin-embedded biopsies from a canine cancer clinical trial; γH2AX/CC3 colocalization analysis revealed apoptosis induction by two novel indenoisoquinoline topoisomerase I inhibitors, which was consistent with pathologist-assessed apoptosis and reduction of tumor volume. This assay is ready for use in clinical trials to elucidate the mechanism of action of investigational agents and combination regimens intended to inflict DNA damage, apoptotic cell death, or both.
    Language English
    Publishing date 2018-03-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.24936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolens.

    Grkovic, Tanja / Evans, Jason R / Akee, Rhone K / Guo, Liang / Davis, Myrtle / Jato, Johnson / Grothaus, Paul G / Ahalt-Gottholm, Michelle / Hollingshead, Melinda / Collins, Jerry M / Newman, David J / O'Keefe, Barry R

    Bioorganic & medicinal chemistry letters

    2018  Volume 29, Issue 2, Page(s) 134–137

    Abstract: Two new cassaine-type diterpenoids, namely erythrofordins D (1) and E (2), sourced from a Cameroon collection of Erythrophleum suaveolens were isolated and assessed for anti-tumor activity. In the NCI-60 cancer cell assay, erythrofordins D (1) and E (2) ... ...

    Abstract Two new cassaine-type diterpenoids, namely erythrofordins D (1) and E (2), sourced from a Cameroon collection of Erythrophleum suaveolens were isolated and assessed for anti-tumor activity. In the NCI-60 cancer cell assay, erythrofordins D (1) and E (2) were found to be cytotoxic in the low micro molar ranges with a mean GI
    MeSH term(s) Caesalpinia/chemistry ; Cell Survival/drug effects ; Diterpenes/chemistry ; Diterpenes/isolation & purification ; Diterpenes/pharmacology ; Dose-Response Relationship, Drug ; Humans ; Molecular Structure ; Myocytes, Cardiac/drug effects ; Structure-Activity Relationship
    Chemical Substances Diterpenes
    Language English
    Publishing date 2018-12-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2018.12.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The hollow fibre model in cancer drug screening: the NCI experience.

    Decker, S / Hollingshead, M / Bonomi, C A / Carter, J P / Sausville, E A

    European journal of cancer (Oxford, England : 1990)

    2004  Volume 40, Issue 6, Page(s) 821–826

    Abstract: The in vivo hollow fibre model was developed by the National Cancer Institute (NCI) in the United States of America (USA) at a time when the number of potential anti-cancer drugs arising from in vitro screening efforts exceeded the available capacity for ...

    Abstract The in vivo hollow fibre model was developed by the National Cancer Institute (NCI) in the United States of America (USA) at a time when the number of potential anti-cancer drugs arising from in vitro screening efforts exceeded the available capacity for testing in traditional xenograft models. Updated analysis of the predictive value of the hollow fibre model continues to indicate that the greater the response in the hollow fibre assay, the more likely it is that activity will be seen in subsequent xenograft models. The original 12 cell line hollow fibre panel has been supplemented with histology-specific panels, and we begin here to analyse their utility in predicting activity in subsequent in vivo models. The key goal of using the hollow fibre model as a way to decrease the cost, both financial and in the number of animals used, to evaluate initial evidence of a compound's capacity to act across physiological barriers continues to be reinforced with our enlarging experience.
    MeSH term(s) Animals ; Antineoplastic Agents/therapeutic use ; Drug Design ; Drug Screening Assays, Antitumor/methods ; Forecasting ; Mice ; Models, Biological ; Neoplasm Transplantation ; Neoplasms/drug therapy ; Predictive Value of Tests ; Transplantation, Heterologous ; Tumor Cells, Cultured
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2004-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 82061-1
    ISSN 1879-0852 ; 0959-8049 ; 0277-5379 ; 0964-1947
    ISSN (online) 1879-0852
    ISSN 0959-8049 ; 0277-5379 ; 0964-1947
    DOI 10.1016/j.ejca.2003.11.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Antibody isotypes against the surface glycoproteins of porcine coronavirus in the milk of orally infected sows.

    De Buysscher, E / Hollingshead, M

    Advances in experimental medicine and biology

    1987  Volume 216B, Page(s) 1025–1031

    MeSH term(s) Animals ; Antibodies, Viral/biosynthesis ; Coronaviridae/immunology ; Female ; Gastroenteritis, Transmissible, of Swine/complications ; Gastroenteritis, Transmissible, of Swine/immunology ; Glycoproteins/immunology ; Immunoglobulin A/biosynthesis ; Immunoglobulin G/biosynthesis ; Immunoglobulin Isotypes/biosynthesis ; Milk/immunology ; Pregnancy ; Pregnancy Complications, Infectious/immunology ; Swine ; Transmissible gastroenteritis virus/immunology ; Viral Proteins/immunology ; Viral Structural Proteins
    Chemical Substances Antibodies, Viral ; Glycoproteins ; Immunoglobulin A ; Immunoglobulin G ; Immunoglobulin Isotypes ; Viral Proteins ; Viral Structural Proteins
    Language English
    Publishing date 1987
    Publishing country United States
    Document type Journal Article
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top